Quality of life during chemotherapy in lung cancer patients: results across different treatment lines
| العنوان: | Quality of life during chemotherapy in lung cancer patients: results across different treatment lines |
|---|---|
| المؤلفون: | L M, Wintner, J M, Giesinger, A, Zabernigg, M, Sztankay, V, Meraner, G, Pall, W, Hilbe, B, Holzner |
| المصدر: | British Journal of Cancer |
| سنة النشر: | 2013 |
| مصطلحات موضوعية: | Male, Lung Neoplasms, multiple treatment lines, Palliative Care, palliative chemotherapy, Middle Aged, humanities, Neoadjuvant Therapy, lung cancer, quality of life, Ambulatory Care, Clinical Study, Humans, Female, electronic patient-reported outcome monitoring, Aged |
| الوصف: | Background: Most lung cancer patients are diagnosed at an advanced disease stage and predominantly receive palliative treatment, which increasingly consists of several chemotherapy lines. We report on patients' quality of life (QOL) to gain knowledge on QOL during and across multiple lines of chemotherapy. This includes patients with (neo)adjuvant therapy up to 3rd or above line palliative chemotherapy. Methods: Lung cancer patients receiving outpatient chemotherapy at the Kufstein County Hospital completed an electronic version of the EORTC QLQ-C30. Linear mixed models were used for statistical analysis. Results: One hundred and eighty seven patients were included in the study. Surprisingly, irrespective of the chemotherapy line patients reported stable QOL scores during treatment. None of the calculated monthly change rates attained clinical significance, referring to established guidelines that classify a small clinical meaningful change as 5 to 10 points. According to treatment line, 3rd or above line palliative chemotherapy was associated with the worst QOL scores, whereas patients undergoing (neo)adjuvant or 1st line palliative chemotherapy reported fairly comparable QOL. Conclusion: The essential finding of our study is that all QOL aspects of the EORTC QLQ-C30 questionnaire remained unchanged during each chemotherapy line in an unselected population of lung cancer patients. Between treatment lines pronounced differences were found, indicating that later palliative chemotherapy lines are associated with higher QOL impairments. These changes in QOL may not primarily be related to the treatment, but rather refer to impairments due to disease progression and may be partly due to a consequence of the prior therapies. |
| تدمد: | 1532-1827 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=pmid________::18b9abc0ae44fd98eb1e2f2be15bdadb https://pubmed.ncbi.nlm.nih.gov/24091620 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.pmid..........18b9abc0ae44fd98eb1e2f2be15bdadb |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.pmid..........18b9abc0ae44fd98eb1e2f2be15bdadb 774 3 unknown 773.956909179688 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........18b9abc0ae44fd98eb1e2f2be15bdadb&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=pmid________::18b9abc0ae44fd98eb1e2f2be15bdadb# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Quality of life during chemotherapy in lung cancer patients: results across different treatment lines
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22L+M%2C+Wintner%22">L M, Wintner</searchLink><br /><searchLink fieldCode="AR" term="%22J+M%2C+Giesinger%22">J M, Giesinger</searchLink><br /><searchLink fieldCode="AR" term="%22A%2C+Zabernigg%22">A, Zabernigg</searchLink><br /><searchLink fieldCode="AR" term="%22M%2C+Sztankay%22">M, Sztankay</searchLink><br /><searchLink fieldCode="AR" term="%22V%2C+Meraner%22">V, Meraner</searchLink><br /><searchLink fieldCode="AR" term="%22G%2C+Pall%22">G, Pall</searchLink><br /><searchLink fieldCode="AR" term="%22W%2C+Hilbe%22">W, Hilbe</searchLink><br /><searchLink fieldCode="AR" term="%22B%2C+Holzner%22">B, Holzner</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => British Journal of Cancer ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2013 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Lung+Neoplasms%22">Lung Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22multiple+treatment+lines%22">multiple treatment lines</searchLink><br /><searchLink fieldCode="DE" term="%22Palliative+Care%22">Palliative Care</searchLink><br /><searchLink fieldCode="DE" term="%22palliative+chemotherapy%22">palliative chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22humanities%22">humanities</searchLink><br /><searchLink fieldCode="DE" term="%22Neoadjuvant+Therapy%22">Neoadjuvant Therapy</searchLink><br /><searchLink fieldCode="DE" term="%22lung+cancer%22">lung cancer</searchLink><br /><searchLink fieldCode="DE" term="%22quality+of+life%22">quality of life</searchLink><br /><searchLink fieldCode="DE" term="%22Ambulatory+Care%22">Ambulatory Care</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+Study%22">Clinical Study</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22electronic+patient-reported+outcome+monitoring%22">electronic patient-reported outcome monitoring</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background: Most lung cancer patients are diagnosed at an advanced disease stage and predominantly receive palliative treatment, which increasingly consists of several chemotherapy lines. We report on patients' quality of life (QOL) to gain knowledge on QOL during and across multiple lines of chemotherapy. This includes patients with (neo)adjuvant therapy up to 3rd or above line palliative chemotherapy. Methods: Lung cancer patients receiving outpatient chemotherapy at the Kufstein County Hospital completed an electronic version of the EORTC QLQ-C30. Linear mixed models were used for statistical analysis. Results: One hundred and eighty seven patients were included in the study. Surprisingly, irrespective of the chemotherapy line patients reported stable QOL scores during treatment. None of the calculated monthly change rates attained clinical significance, referring to established guidelines that classify a small clinical meaningful change as 5 to 10 points. According to treatment line, 3rd or above line palliative chemotherapy was associated with the worst QOL scores, whereas patients undergoing (neo)adjuvant or 1st line palliative chemotherapy reported fairly comparable QOL. Conclusion: The essential finding of our study is that all QOL aspects of the EORTC QLQ-C30 questionnaire remained unchanged during each chemotherapy line in an unselected population of lung cancer patients. Between treatment lines pronounced differences were found, indicating that later palliative chemotherapy lines are associated with higher QOL impairments. These changes in QOL may not primarily be related to the treatment, but rather refer to impairments due to disease progression and may be partly due to a consequence of the prior therapies. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1532-1827 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=pmid________::18b9abc0ae44fd98eb1e2f2be15bdadb" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=pmid________::18b9abc0ae44fd98eb1e2f2be15bdadb</link><br /><link linkTarget="URL" linkTerm="https://pubmed.ncbi.nlm.nih.gov/24091620" linkWindow="_blank">https://pubmed.ncbi.nlm.nih.gov/24091620</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.pmid..........18b9abc0ae44fd98eb1e2f2be15bdadb ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Male
[Type] => general
)
[1] => Array
(
[SubjectFull] => Lung Neoplasms
[Type] => general
)
[2] => Array
(
[SubjectFull] => multiple treatment lines
[Type] => general
)
[3] => Array
(
[SubjectFull] => Palliative Care
[Type] => general
)
[4] => Array
(
[SubjectFull] => palliative chemotherapy
[Type] => general
)
[5] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[6] => Array
(
[SubjectFull] => humanities
[Type] => general
)
[7] => Array
(
[SubjectFull] => Neoadjuvant Therapy
[Type] => general
)
[8] => Array
(
[SubjectFull] => lung cancer
[Type] => general
)
[9] => Array
(
[SubjectFull] => quality of life
[Type] => general
)
[10] => Array
(
[SubjectFull] => Ambulatory Care
[Type] => general
)
[11] => Array
(
[SubjectFull] => Clinical Study
[Type] => general
)
[12] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[13] => Array
(
[SubjectFull] => Female
[Type] => general
)
[14] => Array
(
[SubjectFull] => electronic patient-reported outcome monitoring
[Type] => general
)
[15] => Array
(
[SubjectFull] => Aged
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Quality of life during chemotherapy in lung cancer patients: results across different treatment lines
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => L M, Wintner
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => J M, Giesinger
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => A, Zabernigg
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => M, Sztankay
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => V, Meraner
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => G, Pall
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => W, Hilbe
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => B, Holzner
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 11
[M] => 06
[Type] => published
[Y] => 2013
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 15321827
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 109
)
[1] => Array
(
[Type] => issue
[Value] => 9
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => British journal of cancer
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |